EP1549291A4 - Formulation d'injection - Google Patents

Formulation d'injection

Info

Publication number
EP1549291A4
EP1549291A4 EP03725918A EP03725918A EP1549291A4 EP 1549291 A4 EP1549291 A4 EP 1549291A4 EP 03725918 A EP03725918 A EP 03725918A EP 03725918 A EP03725918 A EP 03725918A EP 1549291 A4 EP1549291 A4 EP 1549291A4
Authority
EP
European Patent Office
Prior art keywords
injection formulation
formulation
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03725918A
Other languages
German (de)
English (en)
Other versions
EP1549291A1 (fr
Inventor
Craig Robert Bunt
Colin Roger Ogle
Michael John Rathbone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interag
Original Assignee
Interag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interag filed Critical Interag
Publication of EP1549291A1 publication Critical patent/EP1549291A1/fr
Publication of EP1549291A4 publication Critical patent/EP1549291A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EP03725918A 2002-05-16 2003-05-16 Formulation d'injection Withdrawn EP1549291A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ51899702A NZ518997A (en) 2002-05-16 2002-05-16 Injection formulation for parenteral administration of biodegradable implant for sustained release of active agent
NZ51899702 2002-05-16
PCT/NZ2003/000095 WO2003097009A1 (fr) 2002-05-16 2003-05-16 Formulation d'injection

Publications (2)

Publication Number Publication Date
EP1549291A1 EP1549291A1 (fr) 2005-07-06
EP1549291A4 true EP1549291A4 (fr) 2008-08-20

Family

ID=29546531

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03725918A Withdrawn EP1549291A4 (fr) 2002-05-16 2003-05-16 Formulation d'injection

Country Status (6)

Country Link
EP (1) EP1549291A4 (fr)
JP (1) JP2005538052A (fr)
AU (1) AU2003228174A1 (fr)
CA (1) CA2486133A1 (fr)
NZ (1) NZ518997A (fr)
WO (1) WO2003097009A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1848431B1 (fr) 2005-02-09 2016-02-03 Santen Pharmaceutical Co., Ltd. Formulations liquides pour le traitement de maladies ou affections
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
JP5636640B2 (ja) * 2009-06-23 2014-12-10 栗田工業株式会社 金属電解コンデンサ用吸収材
JP5382328B2 (ja) * 2009-06-23 2014-01-08 栗田工業株式会社 金属電解コンデンサ用漏洩防止材
JP5636637B2 (ja) * 2009-06-02 2014-12-10 栗田工業株式会社 金属電解コンデンサ
TWI480908B (zh) * 2009-06-02 2015-04-11 Kurita Water Ind Ltd Metal electrolytic capacitors and metal electrolytic capacitors with absorbent materials and leak-proof materials
JP5382327B2 (ja) * 2009-06-02 2014-01-08 栗田工業株式会社 金属電解コンデンサ

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902799A (en) * 1989-04-23 1999-05-11 The Trustees Of The University Of Pennsylvania Methods of modulating tissue growth and regeneration
WO2000071079A2 (fr) * 1999-05-21 2000-11-30 American Bioscience, Inc. Agents a stabilisation proteinique actifs pharmacologiquement; procedes de fabrication et methodes d'utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
US6436424B1 (en) * 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
EP2283880A3 (fr) * 2000-03-20 2014-07-09 Biosphere Medical, Inc. Microspheres injectables pour la regeneration tissulaire

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902799A (en) * 1989-04-23 1999-05-11 The Trustees Of The University Of Pennsylvania Methods of modulating tissue growth and regeneration
WO2000071079A2 (fr) * 1999-05-21 2000-11-30 American Bioscience, Inc. Agents a stabilisation proteinique actifs pharmacologiquement; procedes de fabrication et methodes d'utilisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO03097009A1 *

Also Published As

Publication number Publication date
WO2003097009A1 (fr) 2003-11-27
AU2003228174A1 (en) 2003-12-02
CA2486133A1 (fr) 2003-11-27
NZ518997A (en) 2004-12-24
JP2005538052A (ja) 2005-12-15
EP1549291A1 (fr) 2005-07-06

Similar Documents

Publication Publication Date Title
GB2397767B (en) Injection device
GB0229384D0 (en) Injection device
GB0210123D0 (en) Injection device
AU2003256508A8 (en) Activation-based injection device
GB0211294D0 (en) Improvements relating to injection devices
EP1589901A4 (fr) Injection intracutanee
IL172597A0 (en) Injection device
GB0205066D0 (en) Improvements relating to injection devices
GB0319874D0 (en) Novel formulation
GB0207438D0 (en) Formulation
AU2003259457A8 (en) Auto-destructible syringe
GB0205504D0 (en) Formulation
GB0318448D0 (en) Formulation
GB0312195D0 (en) Formulation
EP1549291A4 (fr) Formulation d'injection
GB0320522D0 (en) Formulation
GB0217285D0 (en) Syringes
GB0303876D0 (en) Formulation
EP1507542A4 (fr) Preparation anticancereuse
GB0214147D0 (en) Formulations
GB0305560D0 (en) Fuel formulations
EP1693113A4 (fr) Disperseur d'injection
GB0213005D0 (en) Injection nozzle
GB0215589D0 (en) Formulation
GB0215591D0 (en) Formulation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041207

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20080717

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20081016